A case of central nervous system lupus in succession to lupus peritonitis: A difficulty in the differential diagnosis between lupus psychosis and steroid-induced psychosis

Modern Rheumatology

Volumn 14, Issue 4, 2004, Pages 323-326

  Murata, Miki ^a,b   Hashiramoto, Akira ^a,b   Yamaguchi, Toru ^a   Takabayashi, Chihiro ^b   Yamane, Takashi ^b   Miura, Yasushi ^a,b   Baba, Hisamitsu ^b,c   Chihara, Kazuo ^a   Shiozawa, Shunichi ^a,b  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY HOSPITAL   (Japan)

^c KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Central nervous system (CNS) lupus; Lupus peritonitis; Lupus psychosis; Steroid induced psychosis

Indexed keywords

ANTINUCLEAR ANTIBODY; CHLORPROMAZINE; DIURETIC AGENT; FUROSEMIDE; HALOPERIDOL; IMMUNOGLOBULIN G; INTERLEUKIN 6; METHYLPREDNISOLONE; PREDNISOLONE; SPIRONOLACTONE;

ADULT; ARTICLE; ASCITES; ASPIRATION BIOPSY; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED DISEASE; DRUG PULSE THERAPY; ECHOGRAPHY; FEMALE; HUMAN; LABORATORY TEST; NEUROLOGIC DISEASE; PERITONITIS; PLEURA EFFUSION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; X RAY;

EID: 20444410829     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10165-004-0318-1     Document Type: Article

References (10)

1. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
2. ACR Ad Hoc Commitment on Neuropsychiatric Lupus Nomenclature. The America College of Rheumatology nomenclature and classification and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
3. Hirohata S. Neuropsychiatric manifestation in systemic lupus erythematosus. Sogo-Rinsho 2002;51:2155-60.
4. Harris EN, Hughes GRV. Cerebral disease in systemic lupus erythematosus. Springer Semin Immunopathol 1985;8:251-66.
5. Jennekens FGI, Kater L. The central nervous system in systemic lupus erythematosus. Part 2. Pathogenic mechanism of clinical syndromes: A literature investigation. Rheumatology 2002;41:619-30.
6. Hirohata S, Hirose S, Miyamoto T. Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Arch Intern Med 1985;145:1843-6.
7. Isshi K, Hirohata S. Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1996;39:1483-90.
8. Isshi K, Hirohata S. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum 1998;41:1819-27.
9. Hirohata S, Miyamoto T. Elevated level of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum 1990;33:644-9.
10. Shiozawa S, Kuroki Y, Kim M, Hirohata S, Ogino T. Interferon-alpha in lupus psychosis. Arthritis Rheum 1992;35:417-22.